Status:

UNKNOWN

Telerehabilitation Protocols With Digital and Robotic Tools for People With Chronic Neurological Disorders

Lead Sponsor:

Fondazione Don Carlo Gnocchi Onlus

Collaborating Sponsors:

Fondazione Ico Falck

Conditions:

Post-stroke

Parkinson Disease

Eligibility:

All Genders

25-85 years

Phase:

NA

Brief Summary

The goal of this clinical trial is to test an innovative telerehabilitation protocol in people with Chronic Neurological Disorders (Parkinson's disease, Multiple Sclerosis, and post-stroke). The main ...

Eligibility Criteria

Inclusion

  • diagnosis of chronic post-stroke condition with ischemic or haemorrhagic stroke injury occurred 4-6months before recruitment and with motor impairment of the upper limb \> 2 to the Medical Research Council scale (MRC); or diagnosis of probable PD according to MDS criteria (Postuma et al., 2015) in staging between 1.5 and 3 on the Hoehn \& Yahr scale (Goetz et al., 2004); or diagnosis of MS, RR-SP forms, according to the criteria of MC Donald 2010 (Polman et al., 2011) with disability level at the Expanded Disability Status Scale EDSS (Kurtzke, 1983) \< 6;
  • age between 25 and 85 years;
  • preserved cognitive level at the Montreal Cognitive Assessment test (MoCA test \>17.36) (Conti et al., 2015);
  • agreement to participate with the signature of the informed consent form;
  • no rehabilitation program in place at the time of enrolment;
  • stable drug treatment (last 3 months) with L-Dopa or dopamine agonists (PD group) and/or cortisone (MS group).

Exclusion

  • presence of comorbidities that might prevent patients from undertaking a safe home program or determining clinical instability (i.e., severe orthopedic or severe cognitive deficits);
  • presence of major psychiatric complications or personality disorders;
  • presence of severe impairment of visual and/or acoustic perception;
  • relapse ongoing/at least 3 months since the last relapse (MS group);
  • presence of "frequent" freezing as recorded at the administration of Section II (daily life activity) of the UPDRS (score ≥ 3) (PD group);
  • falls resulting in injuries or a number of falls ≤ 2 in the 6 months prior to recruitment (PD and MS groups).

Key Trial Info

Start Date :

September 1 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

January 1 2025

Estimated Enrollment :

90 Patients enrolled

Trial Details

Trial ID

NCT06009770

Start Date

September 1 2023

End Date

January 1 2025

Last Update

August 24 2023

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.